Literature DB >> 21215722

Development and characterization of immobilized cannabinoid receptor (CB1/CB2) open tubular column for on-line screening.

R Moaddel1, A Rosenberg, K Spelman, J Frazier, C Frazier, S Nocerino, A Brizzi, C Mugnaini, I W Wainer.   

Abstract

Cannabinoid receptors, CB1 and CB2, are therapeutic targets in the treatment of anxiety, obesity, movement disorders, glaucoma, and pain. We have developed an on-line screening method for CB1 and CB2 ligands, where cellular membrane fragments of a chronic myelogenous leukemia cell line, KU-812, were immobilized onto the surface of an open tubular (OT) capillary to create a CB1/CB2-OT column. The binding activities of the immobilized CB1/CB2 receptors were established using frontal affinity chromatographic techniques. This is the first report that confirms the presence of functional CB1 and CB2 receptors on KU-812 cells. The data from this study confirm that the CB1/CB2-OT column can be used to determine the binding affinities (K(i) values) for a single compound and to screen individual compounds or a mixture of multiple compounds. The CB1/CB2-OT column was also used to screen a botanical matrix, Zanthoxylum clava-herculis, where preliminary results suggest the presence of a high-affinity phytocannabinoid. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21215722      PMCID: PMC3053438          DOI: 10.1016/j.ab.2010.12.034

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  29 in total

1.  A light and electron microscopic study of the CB1 cannabinoid receptor in the primate spinal cord.

Authors:  W Y Ong; K Mackie
Journal:  J Neurocytol       Date:  1999-01

2.  Agonist-inverse agonist characterization at CB1 and CB2 cannabinoid receptors of L759633, L759656, and AM630.

Authors:  R A Ross; H C Brockie; L A Stevenson; V L Murphy; F Templeton; A Makriyannis; R G Pertwee
Journal:  Br J Pharmacol       Date:  1999-02       Impact factor: 8.739

Review 3.  Endocannabinoids in the immune system and cancer.

Authors:  Daniela Parolaro; P Massi; T Rubino; E Monti
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2002 Feb-Mar       Impact factor: 4.006

4.  Structural features of the central cannabinoid CB1 receptor involved in the binding of the specific CB1 antagonist SR 141716A.

Authors:  D Shire; B Calandra; M Delpech; X Dumont; M Kaghad; G Le Fur; D Caput; P Ferrara
Journal:  J Biol Chem       Date:  1996-03-22       Impact factor: 5.157

Review 5.  Pharmacology of cannabinoid CB1 and CB2 receptors.

Authors:  R G Pertwee
Journal:  Pharmacol Ther       Date:  1997       Impact factor: 12.310

Review 6.  International Union of Pharmacology. XXVII. Classification of cannabinoid receptors.

Authors:  A C Howlett; F Barth; T I Bonner; G Cabral; P Casellas; W A Devane; C C Felder; M Herkenham; K Mackie; B R Martin; R Mechoulam; R G Pertwee
Journal:  Pharmacol Rev       Date:  2002-06       Impact factor: 25.468

7.  Frontal affinity chromatography-mass spectrometry useful for characterization of new ligands for GPR17 receptor.

Authors:  Enrica Calleri; Stefania Ceruti; Gloria Cristalli; Claudia Martini; Caterina Temporini; Chiara Parravicini; Rosaria Volpini; Simona Daniele; Gabriele Caccialanza; Davide Lecca; Catia Lambertucci; Maria Letizia Trincavelli; Gabriella Marucci; Irving W Wainer; Graziella Ranghino; Piercarlo Fantucci; Maria P Abbracchio; Gabriella Massolini
Journal:  J Med Chem       Date:  2010-05-13       Impact factor: 7.446

8.  Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations.

Authors:  S Galiègue; S Mary; J Marchand; D Dussossoy; D Carrière; P Carayon; M Bouaboula; D Shire; G Le Fur; P Casellas
Journal:  Eur J Biochem       Date:  1995-08-15

9.  Development and characterization of an open tubular column containing immobilized P-glycoprotein for rapid on-line screening for P-glycoprotein substrates.

Authors:  Ruin Moaddel; Peter L Bullock; Irving W Wainer
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2004-01-25       Impact factor: 3.205

10.  Evidence for cannabinoid receptor-dependent and -independent mechanisms of action in leukocytes.

Authors:  Barbara L Faubert Kaplan; Cheryl E Rockwell; Norbert E Kaminski
Journal:  J Pharmacol Exp Ther       Date:  2003-06-12       Impact factor: 4.030

View more
  16 in total

1.  Investigations on the 4-quinolone-3-carboxylic acid motif part 5: modulation of the physicochemical profile of a set of potent and selective cannabinoid-2 receptor ligands through a bioisosteric approach.

Authors:  Claudia Mugnaini; Stefania Nocerino; Valentina Pedani; Serena Pasquini; Andrea Tafi; Maria De Chiaro; Luca Bellucci; Massimo Valoti; Francesca Guida; Livio Luongo; Stefania Dragoni; Alessia Ligresti; Avraham Rosenberg; Daniele Bolognini; Maria Grazia Cascio; Roger G Pertwee; Ruin Moaddel; Sabatino Maione; Vincenzo Di Marzo; Federico Corelli
Journal:  ChemMedChem       Date:  2012-03-02       Impact factor: 3.466

2.  Identification of metabolites of propyrisulfuron in rats.

Authors:  Tomoyuki Takaku; Kazuki Mikata; Hirohisa Nagahori; Yoshihisa Sogame
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2014-02-22       Impact factor: 3.205

Review 3.  Multiple protein stationary phases: a review.

Authors:  N S Singh; K-L Habicht; K S S Dossou; R Shimmo; I W Wainer; R Moaddel
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2014-04-13       Impact factor: 3.205

4.  Stabilized phospholipid membranes in chromatography: toward membrane protein-functionalized stationary phases.

Authors:  Elyssia S Gallagher; Elisabeth Mansfield; Craig A Aspinwall
Journal:  Anal Bioanal Chem       Date:  2014-01-05       Impact factor: 4.142

Review 5.  Targeting Anti-Cancer Active Compounds: Affinity-Based Chromatographic Assays.

Authors:  Marcela Cristina de Moraes; Carmen Lucia Cardoso; Cláudia Seidl; Ruin Moaddel; Quezia Bezerra Cass
Journal:  Curr Pharm Des       Date:  2016       Impact factor: 3.116

6.  In vivo inflammation imaging using a CB2R-targeted near infrared fluorescent probe.

Authors:  Shaojuan Zhang; Pin Shao; Xiaoxi Ling; Ling Yang; Weizhou Hou; Steve H Thorne; Wissam Beaino; Carolyn J Anderson; Ying Ding; Mingfeng Bai
Journal:  Am J Nucl Med Mol Imaging       Date:  2015-02-15

7.  Development and preliminary validation of a plate-based CB1/CB2 receptor functional assay.

Authors:  K S S Dossou; K P Devkota; P V Kavanagh; J A Beutler; J M Egan; R Moaddel
Journal:  Anal Biochem       Date:  2013-03-07       Impact factor: 3.365

Review 8.  Comparison of analytical techniques for the identification of bioactive compounds from natural products.

Authors:  Łukasz Cieśla; Ruin Moaddel
Journal:  Nat Prod Rep       Date:  2016-07-01       Impact factor: 13.423

9.  Development and characterization of the α3β4α5 nicotinic receptor cellular membrane affinity chromatography column and its application for on line screening of plant extracts.

Authors:  L Ciesla; M Okine; A Rosenberg; K S S Dossou; L Toll; I W Wainer; R Moaddel
Journal:  J Chromatogr A       Date:  2015-12-29       Impact factor: 4.759

Review 10.  Matching the power of high throughput screening to the chemical diversity of natural products.

Authors:  Curtis J Henrich; John A Beutler
Journal:  Nat Prod Rep       Date:  2013-08-08       Impact factor: 13.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.